Jerri Ivey


Negotiating better managed care contracts

Jerri Ivey, director of revenue cycle management at VitalSkin Dermatology, shares steps you can take and ways you can educate yourself in order to negotiate better managed care contracts. 

Helen Park


Looking at the scalp and nails during a skin exam is key

A presentation from the 2021 virtual American Academy of Pediatrics Conference & Exhibition urges including examination of the scalp and nails during any skin exam.

Vikash Oza, MD


Take-Home Points

Joshua Zeichner, MD; Brittany Craiglow, MD; Elizabeth Swanson, MD; Vikash Oza, MD; and Raj Chovatiya, MD, PhD, provide take-home messages for dermatologists treating pediatric patients with atopic dermatitis.

Mazi Rasulnia, PhD, MPH, MBA


Addressing Differences in Patient Engagement Across Racial and Ethnic Groups

There are interesting differences in the ways patients of varying ethnicities and races engage with technology.

Syed Nishat, BFA


Tax Increases Coming? What Physicians Need to Know About the Inflation Reduction Act

The sweeping legislation contains tax code reform, health care provisions and climate change action. What does it mean for physicians?

Adam Friedman, MD, FAAD


Grant Program Accepting Applications, Seeks to Bridge Care Gap in Inflammatory Dermatoses

Grant applications are open from now until August 24, 2023, with an anticipated project start/end date of January 2024 through July 2025.

Nicole Vélez, MD, FACMS


Grow Your Practice With the Right Marketing and SEO

Nicole Vélez, MD, provided marketing pearls to streamline mundane tasks and promote your practice in the digital world.

Roy M. Fleischmann, MD


Addressing Patients' Concerns With Biosimilars

Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.

Gabrielle Ientile


2021 Acne Updates: New Drugs and Research

A presentation from Maui Derm Live 2021 featured insights on new drugs and data in acne.

Dorothy McCabe, PhD, FCP


Cyltezo Biosimilar Launches Today in the US

Boehringer Ingelheim’s Cyltezo is the first and only FDA-approved interchangeable biosimilar to adalimumab.

Fred Gebhart


The JAK Inhibitor Pipeline Builds in Dermatology

Eight JAK inhibitors are approved by the FDA to treat autoimmune, inflammatory, and allergic conditions.

Janet Dyer


Further Research Needed to Study Link Between AD and ADHD

Researchers found an association between ADHD and three inflammatory conditions—atopic dermatitis, otitis media, and herpes simplex infection.

Jennifer Soung, MD


Roflumilast Patient Selection for Plaque Psoriasis Treatment

Experts describe roflumilast patient selection for plaque psoriasis treatment.

Thomas J. Knackstedt, MD, MPH, FACMS


Looking Ahead to the 2023 ACMS Meeting

The ACMS president and scientific program chair share opportunities to discover innovations in Mohs surgery during this weekend’s meeting.

Antonia DePace


Gut Microbiome Can Affect Radiation Cancer Treatment

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

Andrew F. Alexis, MD, MPH


Future Directions in the Treatment of Atopic Dermatitis

Andrew F. Alexis, MD, MPH, and Benjamin N. Lockshin, MD, talk about how clinical approaches and understanding of risk/benefit profiles are evolving in light of the emerging long-term data.

Jeffrey Cohen, MD


Key Takeaways on the Management of Atopic Dermatitis

Panelists share parting advice and key takeaways on the optimal management of atopic dermatitis within the treatment landscape.

Hannah Badon, MD


Dermatologic differences in a diverse population

Understanding the difference in biology and clinical presentations of cutaneous conditions in different skin types is critical for health care professionals to treat a diverse population.

R. Caleb Kovell, MD


The Importance of Collaboration Between Mohs Surgeons and Urologists

Caleb Kovell, MD and Junqian Zhang, MD demonstrated how teaming up increases the likelihood for positive patient outcomes in Mohs cases on the genitalia and perianal region.

Gina Battaglia, PhD, Correspondent


Frontline Forum Part 4: Improving Basal Cell Carcinoma Management

In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.

Stefan Weiss, MD, MHSc, MBA


Understanding How Data Analytics Help Improve Health Outcomes With Stefan Weiss, MD

Weiss is the managing director of dermatology at OM1, a data analytics company with a health care focus.

Lauren Miller, MPAS, PA-C


Deucravacitinib: A Year in Review

As deucravacitinib surpasses its 1-year milestone since approval, clinicians continue to monitor its real-world performance among patients.

Sherrif F. Ibrahim, MD, PhD


BCC Patient Case Impressions

Sherrif F. Ibrahim, MD, PhD, and Vishal Patel, MD, FAAD, FACMS, provide initial impressions of the case and discuss the use of immune checkpoint inhibitors.

Amar Davé, MD, FAAP;


The Dx and Rx of Congenital Malalignment Syndrome in Children

Congenital malalignment syndrome is a nail disorder caused by the lateral rotation of the nail matrix.

© 2023 MJH Life Sciences

All rights reserved.